Adverse events related to low dose corticosteroids in autoimmune hepatitis

BACKGROUND: Autoimmune hepatitis requires long‐term therapy, and systemic corticosteroids are the backbone of therapeutic management. Prolonged use of corticosteroids may lead to adverse events but data from long‐term studies are mainly derived from studies in rheumatic diseases. AIM: To assess cata...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Brand, Floris F., van der Veen, Koen S., Lissenberg‐Witte, Birgit I., de Boer, Ynto S., van Hoek, Bart, Drenth, Joost P. H., Verdonk, Robert C., Vrolijk, Jan M., van Nieuwkerk, Carin M. J., Bouma, Gerd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Safety of Steroids in Autoimmune Hepatitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899908/
https://www.ncbi.nlm.nih.gov/pubmed/31617229
http://dx.doi.org/10.1111/apt.15528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899908/
https://www.ncbi.nlm.nih.gov/pubmed/31617229
http://dx.doi.org/10.1111/apt.15528

Ejemplares similares